|  | RBP4 (ng/mL) | Creatinine (mg/dL) | RBP4/creatinine (ng/mg) |
---|---|---|---|---|
Treatment group | Days after therapy | Â | Â | Â |
Non-treated | Study start | 2.5 (0.2) | 47 (5) | 5.5 (0.7) |
14 | 2.6 (0.3)b | 53 (6) | 5.1 (0.7) | |
30 | 3.5 (0.2) | 50 (6) | 7.5 (0.8) | |
60 | 2.9 (0.3)b | 46 (4) | 6.6 (0.8) | |
90 | 9.6 (2.1) | 51 (5) | 19 (5) | |
60 MBq | Study start | 3.4 (0.3) | 59 (6) | 5.9 (0.6) |
14 | 4.2 (0.8) | 60 (7) | 7.1 (1.2) | |
30 | 5.2 (0.5) | 62 (7) | 8.9 (1.2) | |
60 | 17 (8) | 68 (9) | 31 (17) | |
90 | 57 (28) | 61 (11) | 150 (93) | |
120 MBq | Study start t | 3.5 (0.3)b | 53 (4) | 7 (1) |
14 | 5.6 (0.9) | 48 (6) | 12 (2) | |
30 | 38 (20)a | 43 (5) | 94 (49) | |
60 | 97 (17)a | 22 (4) | 480 (73) | |
90 | 120 (31)a | 41 (4) | 350 (72) |